A recent study found that antiretroviral therapy adherence below 90% was associated with significantly lower odds of viral suppression among women living with HIV. Researchers analyzed data from ...

High stigma levels correlate with lower ART adherence and viral suppression in women with HIV, especially those who inject drugs. The study used data from the WIHS, focusing on stigma's impact on HIV ...

In the early 1980s, as a physician at the University of California Medical Center, researching and treating sexually transmitted viral diseases, I found myself at the epicenter of an emerging crisis ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

Recently incarcerated individuals with HIV face challenges in achieving sustained viral suppression (SVS) due to social conditions and health care access issues. Younger age, recent release, and ...

GSK’s long-acting HIV regimen Cabenuva has already shown it works as well as daily oral therapies in patients who have the virus under control. Now, the injection has beaten daily drugs in individuals ...

To provide a forum and platform for investigators interested in HIV related adherence research to communicate and exchange skills and expertise in support of each other. To make investigators aware of ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

This study assessed longitudinal relationships between patient healthcare empowerment, engagement in care, and viral control in the Women's Interagency HIV Study, a prospective cohort study of U.S.